The clinical manifestations of acromegaly are caused by systemic effects related to the prolonged exposure to GH/IGF-1 excess (musculoskeletal, cardiovascular and metabolic comorbidities) and the local tumor extension (visual-field defects, cranial-nerve palsy and hypopituitarism) [1]. Here, GH1 is linked to acromegaly.